Response to First‐Line Chemotherapy Predicts Response to Maintenance Avelumab Therapy in Japanese Patients With Advanced Urothelial Carcinoma.

Saved in:
Bibliographic Details
Title: Response to First‐Line Chemotherapy Predicts Response to Maintenance Avelumab Therapy in Japanese Patients With Advanced Urothelial Carcinoma.
Authors: Inoue, Satoshi1 (AUTHOR) inoue.satoshi@med.nagoya‐u.ac.jp, Hayakawa, Akira2 (AUTHOR), Kobayashi, Mikinori3 (AUTHOR), Nagasaka, Yuriko4 (AUTHOR), Omi, Takanao5 (AUTHOR), Shamoto, Noritoshi6 (AUTHOR), Ito, Fumihiro7 (AUTHOR), Yuba, Takuma8 (AUTHOR), Yuguchi, Yuri9 (AUTHOR), Kawanishi, Hideji10 (AUTHOR), Tochigi, Kosuke2 (AUTHOR), Akamatsu, Shusuke1 (AUTHOR)
Source: International Journal of Urology. Oct2025, Vol. 32 Issue 10, p1449-1459. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09198172
DOI:10.1111/iju.70162